GB1385033A - Medicine containing immunizing substances for bucco-dental diseases - Google Patents
Medicine containing immunizing substances for bucco-dental diseasesInfo
- Publication number
- GB1385033A GB1385033A GB498472A GB498472A GB1385033A GB 1385033 A GB1385033 A GB 1385033A GB 498472 A GB498472 A GB 498472A GB 498472 A GB498472 A GB 498472A GB 1385033 A GB1385033 A GB 1385033A
- Authority
- GB
- United Kingdom
- Prior art keywords
- lactobacillus
- bucco
- dental
- feb
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0002—Fungal antigens, e.g. Trichophyton, Aspergillus, Candida
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0266—Klebsiella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/085—Staphylococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
- A61K39/092—Streptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/114—Fusobacterium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9728—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Mycology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Birds (AREA)
- Tropical Medicine & Parasitology (AREA)
- Botany (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Cosmetics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
1385033 Dental composition INSTITUT DE RECHERCHE SCIENTIFIQUE 2 Feb 1972 [8 Feb 1971] 4984/72 Heading A5B A pharmaceutical composition active against dental disease comprises (a) a mixture of lysates of human bucco-dental pathogens and saprophytes which have been prepared by the action of an amino acid on the bacterial organisms and sodium deoxycholate on the levuroid organisms; (b) a chemical stabilizer, (c) an antimicrobial preservative and (d) an excipient. The microorganisms may be Lactobacillus Acidophilus, Lactobacillus Helveticus, Lactobacillus Lactis, Lactobacillus Fermentatus, Streptococcus groups A, D and H, Staphylococcus Aureus, Corynebacterium Pseudodiphteriticus, Fusiformis Fusiformis, Klebsiella Pneumoniae and Candida Albicans. The amino acid may be glycine. The lysate may be lyophilized.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR7104139A FR2124124B1 (en) | 1971-02-08 | 1971-02-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1385033A true GB1385033A (en) | 1975-02-26 |
Family
ID=9071533
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB498472A Expired GB1385033A (en) | 1971-02-08 | 1972-02-02 | Medicine containing immunizing substances for bucco-dental diseases |
Country Status (8)
Country | Link |
---|---|
AT (1) | AT315367B (en) |
BE (1) | BE778267A (en) |
CA (1) | CA984294A (en) |
DD (1) | DD95911A1 (en) |
DE (1) | DE2205882C3 (en) |
FR (1) | FR2124124B1 (en) |
GB (1) | GB1385033A (en) |
OA (1) | OA03952A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0009872A1 (en) * | 1978-09-01 | 1980-04-16 | Secretary of State for Social Services in Her Britannic Majesty's Gov. of the U.K. of Great Britain and Northern Ireland | Antigen preparation, process for producing it and pharmacological or dental preparations containing the antigen preparation or antibodies thereto |
-
1971
- 1971-02-08 FR FR7104139A patent/FR2124124B1/fr not_active Expired
-
1972
- 1972-01-20 BE BE778267A patent/BE778267A/en not_active IP Right Cessation
- 1972-01-31 OA OA54480A patent/OA03952A/en unknown
- 1972-02-02 GB GB498472A patent/GB1385033A/en not_active Expired
- 1972-02-03 CA CA133,837A patent/CA984294A/en not_active Expired
- 1972-02-07 AT AT96672A patent/AT315367B/en not_active IP Right Cessation
- 1972-02-07 DD DD160733A patent/DD95911A1/xx unknown
- 1972-02-08 DE DE2205882A patent/DE2205882C3/en not_active Expired
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0009872A1 (en) * | 1978-09-01 | 1980-04-16 | Secretary of State for Social Services in Her Britannic Majesty's Gov. of the U.K. of Great Britain and Northern Ireland | Antigen preparation, process for producing it and pharmacological or dental preparations containing the antigen preparation or antibodies thereto |
Also Published As
Publication number | Publication date |
---|---|
DE2205882A1 (en) | 1972-08-10 |
CA984294A (en) | 1976-02-24 |
DE2205882C3 (en) | 1979-09-20 |
FR2124124B1 (en) | 1974-04-12 |
AT315367B (en) | 1974-05-27 |
DD95911A1 (en) | 1973-02-20 |
OA03952A (en) | 1975-08-14 |
BE778267A (en) | 1972-07-19 |
FR2124124A1 (en) | 1972-09-22 |
DE2205882B2 (en) | 1979-01-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
McCracken | The rate of bacteriologic response to antimicrobial therapy in neonatal meningitis | |
Gudmundsson et al. | The in-vivo postantibiotic effect of imipenem and other new antimicrobials | |
Snanson et al. | Amoxycillin compared with penicillin V for the prophylaxis of dental bacteraemia | |
Fenton et al. | Evaluation of colistin and nalidixic acid in Todd-Hewitt broth for selective isolation of group B streptocci | |
ES2331650T3 (en) | USE OF PROBIOTIC BACTERIA IN THE TREATMENT OF AN INFECTION. | |
Denys et al. | Susceptibility of Propionibacterium acnes clinical isolates to 22 antimicrobial agents | |
Young | Treatment of brucellosis in humans | |
Sims | The clinical bacteriology of purulent oral infections | |
Bue et al. | Efficacy of azithromycin compared with spiramycin in the treatment of odontogenic infections | |
Ørstavik et al. | Clinical and Materials Sciences: Antibacterial Activity of Tooth-Colored Dental Restorative Materials | |
Lowy et al. | Penicillin therapy of experimental endocarditis induced by tolerant Streptococcus sanguis and nontolerant Streptococcus mitis | |
Holmberg et al. | Antimicrobial in vitro susceptibility of Actinomyces israelii and Arachnia propionica | |
Tresadern et al. | Streptococcus milleri and surgical sepsis. | |
GB1385033A (en) | Medicine containing immunizing substances for bucco-dental diseases | |
Jaffe et al. | Staphylococcal sepsis in HIV antibody seropositive psoriasis patients | |
Lütticken et al. | Vancomycin-resistant Streptococcaceae from clinical material | |
Karikalan et al. | Antibiogram of Streptococcus mutans isolated from dental caries patients | |
Phillips et al. | Susceptibifity of Bacteroides fragilis to spectinomycin | |
ROBERTS et al. | Demethylchlortetracycline and Tetracycline: A Critical Comparison: In Vitro Activity, Serum Concentrations, and Effect of Serum Binding | |
TW365538B (en) | Pharmaceutical composition for preventing a bacterial disease of fishes and crustaceans | |
Islam et al. | Primary meningitis caused by Bacteroides fragilis and Fusobacterium necrophorum | |
Basker et al. | Activity of amoxycillin, alone, and in combination with aminoglycoside antibiotics against streptococci associated with bacterial endocarditis | |
Ginsburg | Streptococcus. | |
Hunt et al. | In vitro antibiotic sensitivity of oral microorganisms to actinobolin | |
Diana et al. | The effect of curcuma xanthorrhiza ethanol extract on the viability of streptococcus mutans and aggregatibacter actinomycetemcomitans (Dental biofilm research: In vitro study) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PS | Patent sealed | ||
PE20 | Patent expired after termination of 20 years |